Radius Health Inc (RDUS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

ATTN: CHIEF FINANCIAL OFFICER WALTHAM, MA 02451

Radius Health Inc. researches and develops drug therapies. The company focuses on helping treat osteoporosis by building new bone in patients, and women's health conditions including menopause and age-related muscle loss. Radius Health conducts business in the United States.

Data based on most recent fiscal year report
Market Cap1.607 Billion Shares Outstanding44.59 Million Avg Volume1.496 Million
1-Yr BETA vs S&P TR Current Ratio5.04 Quick Ratio4.96
View SEC Filings from RDUS instead.
Q4 2018 All Institutions Hedge Funds 1
To trade RDUS now:
Filers who had this stock in their top 10: 3 3 (0.3%)
13F Filers holding this stock: 118 26 (2.6%)
Aggregate 13F shares on 12/31/2018: 48.092 Million 16.138 Million
Aggregate 13F shares on 09/30/2018: 49.277 Million 15.482 Million
Percent change: -2.41% 4.23%
Funds creating new positions: 22 5
Funds Adding to an existing position: 49 10
Funds closing out their position: 37 11
Funds reducing their position: 32 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RDUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

60 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

33.6 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUGHES OWEN

  • Director
4,800 2019-02-13 1

GRAVES KURT

  • Director
4,800 2019-02-13 1

GADICKE ANSBERT

  • Director
  • 10% Owner
195,902 2019-02-13 0

DERE WILLARD H

  • Director
4,800 2019-02-13 1

ROSENBERG ANTHONY

  • Director
4,800 2019-02-13 1

ROYCHOWDHURY DEBASISH

  • Director
4,800 2019-02-13 1

FRIEDMAN CATHY

  • Director
4,800 2019-02-13 1

GARNIER JEAN PIERRE

  • Director
4,800 2019-02-13 1

EVNIN LUKE

  • Director
  • 10% Owner
322,063 2019-02-07 0

AUERBACH ALAN H PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
4,204,682 2019-02-06 0

WILLIAMS GREGORY C. CHIEF OPERATING OFFICER

0 2019-01-30 0

WARD ROBERT CHIEF EXECUTIVE OFFICER

0 2019-01-30 0

SNOW DAVID P. CHIEF BUSINESS OFFICER

0 2019-01-30 0

HOPFIELD JESSICA

  • Director
0 2019-01-24 2

O'DEA LOUIS CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-02 0

HATTERSLEY GARY CHIEF SCIENTIFIC OFFICER

  • Officer
1,173 2018-12-31 1

HATZIS-SCHOCH BRENT SR. VP, GENERAL COUNSEL

  • Officer
2,944 2018-12-31 1

FITZPATRICK LORRAINE A. CHIEF MEDICAL OFFICER

  • Officer
989 2018-12-31 1

HOEILAND JESPER PRESIDENT AND CEO

  • Officer
  • Director
13,567 2018-12-31 1

BIOTECH GROWTH N V

BB BIOTECH AG

  • 10% Owner
6,710,276 2018-12-20 3

KELLY JOSEPH FRANCIS SR. VP OF SALES AND MARKETING

  • Officer
3,000 2018-12-17 1

ST PETER STEVEN PRESIDENT AND CEO

  • Officer
  • Director
603,623 2018-12-17 0

WARD ROB

  • Director
7,926,486 2018-10-16 0

MORRIS CHARLES Q CHIEF MEDICAL OFFICER

  • Officer
0 2018-09-04 2

STONER ELIZABETH

  • Director
29,639 2018-08-27 0

VANDER VORT JOHN

  • Director
38,500 2018-07-27 0

CARMONA JOSE CHIEF FINANCIAL OFFICER

  • Officer
0 2018-02-13 0

HARVEY BRIAN NICHOLAS SR. VP AND CFO

  • Officer
76,189 2017-04-25 0

PURANDARE DINESH SVP, HEAD OF GLOBAL ONCOLOGY

  • Officer
0 2017-02-17 0

MPM BIOVENTURES III LLC

HENNER DENNIS

MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES III PARALLEL FUND, L.P.

MPM BIOVENTURES III GP L.P.

MPM BIOVENTURES III L.P.

MPM BIOVENTURES III-QP L.P.

STEINMETZ MICHAEL

  • FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER
No longer subject to file 2016-09-27 0

GALAKATOS NICHOLAS

SIMON NICHOLAS J III

WHEELER KURT

  • FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER
No longer subject to file 2016-09-27 0

MPM BIOVENTURES IV LLC

SCOPA JAMES PAUL

MPM BIOVENTURES IV GP LLC

MPM BIO IV NVS STRATEGIC FUND LP

KAILIAN VAUGHN M

FOLEY TODD

  • FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER
No longer subject to file 2016-09-27 0

WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST

  • 10% Owner
No longer subject to file 2016-08-24 0

HEALTHCARE VENTURES VII LP

CAVANAUGH JAMES H

HEALTHCARE PARTNERS VII, L.P.

LAWLOR AUGUSTINE

LITTLECHILD JOHN W

MIRABELLI CHRISTOPHER

WERNER HAROLD R

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2016-02-17 0

FLEMING JONATHAN

  • Director
0 2015-06-09 0

MUENCHBACH MARTIN

  • Director
0 2015-05-07 0

DURAND MARK EVP & CFO

  • Officer
0 2015-04-29 0

F2 BIOSCIENCE IV L.P.

F2 BIOSCIENCE IV GP LTD.

F2 CAPITAL LTD

PRIESTLEY KATHERINE

F2 BIO VENTURES V L.P.

F2 BIO VENTURES GP LTD.

GLOBEWAYS HOLDINGS LTD

  • 10% Owner
No longer subject to file 2015-01-16 0

F2 BIOSCIENCE III, L.P.

F2 BIOSCIENCE GP LTD.

F2 CAPITAL LTD

PRIESTLEY KATHERINE

GLOBEWAYS HOLDINGS LTD

  • 10% Owner
No longer subject to file 2015-01-16 0

JOVAN-EMBIRICOS MORANA

  • Director
  • 10% Owner
3,834,831 2015-01-08 0

F2 BIOSCIENCE III, L.P.

F2 BIOSCIENCE GP LTD.

F2 CAPITAL LTD

PRIESTLEY KATHERINE

  • 10% Owner
1,167,997 2015-01-08 0

HARRIS ALAN G CHIEF MEDICAL OFFICER

  • Officer
0 2014-12-17 0

F2 BIOSCIENCE VI L.P.

F2 CAPITAL LTD

PRIESTLEY KATHERINE

GLOBEWAYS HOLDINGS LTD

F2 BIOSCIENCE IV GP LTD.

  • 10% Owner
587,500 2014-06-11 0

F2 BIOSCIENCE IV L.P.

F2 BIOSCIENCE IV GP LTD.

F2 CAPITAL LTD

PRIESTLEY KATHERINE

F2 BIO VENTURES V L.P.

F2 BIO VENTURES GP LTD.

GLOBEWAYS HOLDINGS LTD

F2 BIOSCIENCE VI L.P.

  • 10% Owner
3,254,334 2014-06-11 0

MPM BIOVENTURES IV LLC

SCOPA JAMES PAUL

VANDER VORT JOHN

MPM BIOVENTURES IV GP LLC

MPM BIO IV NVS STRATEGIC FUND LP

FOLEY TODD

KAILIAN VAUGHN M

  • 10% Owner
0 2013-04-23 0

MPM BIOVENTURES IV LLC

MPM BIOVENTURES IV GP LLC

MPM BIO IV NVS STRATEGIC FUND LP

FOLEY TODD

KAILIAN VAUGHN M

SCOPA JAMES PAUL

ST PETER STEVEN

VANDER VORT JOHN

  • 10% Owner
0 2011-12-14 0

LYTTLE CECIL RICHARD PRESIDENT AND CEO

  • Officer
  • Director
0 2011-11-07 0

MPM BIOVENTURES IV LLC

MPM BIOVENTURES IV GP LLC

MPM BIO IV NVS STRATEGIC FUND LP

DOMBKOWSKI ASHLEY L

GREENE WILLIAM

KAILIAN VAUGHN M

SCOPA JAMES PAUL

ST PETER STEVEN

VANDER VORT JOHN

  • 10% Owner
0 2011-05-17 0

IPSEN PHARMA SAS

IPSEN, S.A.

  • 10% Owner
  • POSSIBLE 10% BENEFICIAL OWNER
0 2011-05-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GARNIER JEAN PIERRE - Director

2019-02-13 M 4,800 a 4,800 4,800.00 direct

GRAVES KURT - Director

2019-02-13 M 4,800 d 0 4,800.00 direct

FRIEDMAN CATHY - Director

2019-02-13 M 4,800 a 4,800 4,800.00 direct

ROYCHOWDHURY DEBASISH - Director

2019-02-13 M 4,800 a 4,800 4,800.00 direct

ROSENBERG ANTHONY - Director

2019-02-13 M 4,800 d 0 4,800.00 direct

DERE WILLARD H - Director

2019-02-13 M 4,800 a 4,800 4,800.00 direct

HUGHES OWEN - Director

2019-02-13 M 4,800 d 0 4,800.00 direct

GRAVES KURT - Director

2019-02-13 M 4,800 a 4,800 4,800.00 direct

GARNIER JEAN PIERRE - Director

2019-02-13 M 4,800 d 0 4,800.00 direct

ROSENBERG ANTHONY - Director

2019-02-13 M 4,800 a 4,800 4,800.00 direct

FRIEDMAN CATHY - Director

2019-02-13 M 4,800 d 0 4,800.00 direct

ROYCHOWDHURY DEBASISH - Director

2019-02-13 M 4,800 d 0 4,800.00 direct

HUGHES OWEN - Director

2019-02-13 M 4,800 a 4,800 4,800.00 direct

DERE WILLARD H - Director

2019-02-13 M 4,800 d 0 4,800.00 direct

HOPFIELD JESSICA - Director

2019-01-24 A 30,000 a 30,000 0.00 direct

BIOTECH GROWTH N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2018-12-20 P 60,000 $14.48 a 6,710,276 6,710,276.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments